You Didn’t Know That Pesky Infection Was Going to Come Back to Haunt You
Most people have heard of mono, or infectious mononucleosis, the illness famous for causing crushing fatigue, swollen lymph nodes, fever, and a sore throat.
What many people don't realize is that the virus most commonly responsible for mono, Epstein-Barr virus (EBV), doesn't necessarily disappear when you recover.
EBV is a member of the herpesvirus family. After the initial infection, the virus establishes latency, primarily within B lymphocytes, where it can remain for life.
In fact, more than 90% of adults have evidence of previous EBV infection. For most people, that never becomes a problem. But under certain circumstances, EBV can become biologically active again—a process known as reactivation.
This is where understanding EBV becomes more complicated.
First: What Is Mono?
Infectious mononucleosis is a clinical syndrome most commonly caused by a person's first significant infection with EBV.
Classic symptoms can include:
Extreme fatigue
Fever
Sore throat
Swollen lymph nodes, particularly in the neck
Headaches and body aches
Enlarged tonsils
Enlarged spleen
Enlarged liver
Reduced appetite
General weakness or malaise
Bloodwork during acute mono may also show increased lymphocytes, atypical lymphocytes, decreased neutrophils or platelets, and elevated liver enzymes.
Most people recover from acute mono over several weeks, although fatigue can sometimes linger considerably longer.
After the acute infection resolves, however, EBV doesn't leave the body.
It enters a latent state.
What Does EBV Reactivation Mean?
Once you've been infected with EBV, your immune system generally keeps the virus under tight control.
But EBV can periodically reactivate.
When reactivation does coincide with symptoms, people may describe symptoms resembling a milder or prolonged version of their original mono illness.
Possible symptoms may include:
Significant or unexplained fatigue
Reduced exercise tolerance
Swollen or tender lymph nodes
Sore throat
Low-grade fever
Headaches
Muscle or joint aches
General malaise
Difficulty concentrating or "brain fog"
Loss of appetite
Recurrent flu-like episodes
Why Can EBV Reactivate?
EBV exists in a delicate relationship with the immune system.
Your immune system continually surveils EBV-infected cells and normally prevents the virus from becoming clinically significant again.
Reactivation can occur when that immune control changes.
Situations associated with viral reactivation can include:
Significant physiological stress
Acute illness or another infection
Immune suppression
Certain medications that suppress immune function
Organ or stem-cell transplantation
Cancer or cancer treatment
Significant systemic inflammation or illness
Reactivation may also occur without producing recognizable symptoms.
Recurrent EBV vs. Reactivated EBV vs. Chronic Active EBV
These terms are frequently used interchangeably online, but medically they describe very different situations.
EBV Reactivation
The virus was previously acquired, became latent, and subsequently entered a more active phase.
A laboratory pattern that can be seen with reactivation includes:
VCA IgG: Positive
EBNA IgG: Positive
Early Antigen (EA) IgG: Sometimes positive
VCA IgM: Positive or negative
Recurrent Mono-Like Illness
Some patients experience repeated periods of fatigue, swollen glands, sore throat, malaise, or other symptoms reminiscent of their original mono infection.
That doesn't automatically mean they are repeatedly "catching mono."
Because EBV remains in the body, clinicians may investigate whether EBV reactivation is occurring while simultaneously evaluating other possible explanations for the recurring symptoms.
Chronic Active EBV Disease
Chronic active Epstein-Barr virus disease (CAEBV) is something very different.
CAEBV is a rare and potentially life-threatening EBV-associated lymphoproliferative disease involving EBV-infected T or NK cells.
Current diagnostic guidelines require much more than fatigue plus elevated EBV antibodies.
Proposed criteria include:
Persistent or recurrent mono-like symptoms for more than three months
Increased EBV genomes in blood and/or affected tissue
Demonstration of EBV-infected T or NK cells
Illness that cannot be explained by another disease
Updated guidelines propose an EBV DNA level of ≥10,000 IU/mL in whole blood as a diagnostic cutoff, although viral load alone is not sufficient for diagnosis.
CAEBV can involve persistent fever, lymph node enlargement, enlarged liver or spleen, blood abnormalities and organ involvement.
It should not be confused with the much broader, and considerably more controversial, idea of attributing chronic fatigue or nonspecific symptoms to "chronic EBV."
When Symptoms Continue for Months
This is another place where careful evaluation matters.
Persistent fatigue following mono is real, but persistent fatigue doesn't automatically mean persistent EBV infection.
The CDC recommends considering other causes when someone remains ill for more than six months without laboratory-confirmed active EBV disease.
Depending on the patient's symptoms and history, a broader workup might include:
Complete blood count (CBC)
Comprehensive metabolic panel (CMP)
AST and ALT/liver enzymes
Ferritin and complete iron studies
Vitamin B12 and folate
Vitamin D
Thyroid testing
Inflammatory markers such as CRP or ESR
Evaluation for other infections when clinically indicated
Evaluation for autoimmune, hematologic, sleep, endocrine or other disorders when appropriate
The goal isn't simply to find a positive laboratory marker.
The goal is to understand why the patient feels unwell.
The Bigger Picture
EBV is fascinating because infection isn't necessarily a simple event with a beginning and an end.
The first infection may cause mono, or virtually no symptoms at all. Afterward, the virus establishes lifelong latency.
For most people, the immune system keeps EBV under control indefinitely.
For others, EBV may periodically reactivate. And in a very small subset of patients, EBV can contribute to serious EBV-associated diseases that require specialist evaluation.
Understanding those distinctions matters.
When persistent or recurrent symptoms are present, looking at the complete clinical picture and the appropriate laboratory markers can help your provider determine whether you're looking at a new infection, past exposure, possible reactivation, or something else entirely.
While EBNA IgG is primarily considered a marker of past EBV infection and there is no universally accepted EBNA IgG level that independently diagnoses EBV reactivation, we also pay attention to the degree of elevation alongside the patient's symptoms, history, and other laboratory findings.
In our practice, we begin addressing and monitoring EBV when EBNA IgG is greater than 100 U/mL, particularly when the patient is experiencing symptoms consistent with a recurrent or reactivated viral picture.
This does not mean that an EBNA level over 100 proves active EBV infection. EBNA antibodies can remain elevated for life, and antibody values vary between laboratories and testing methods. Instead, we use this threshold as a clinical monitoring point that prompts us to look more closely at the patient's overall picture.
When EBNA IgG is above 100, we may evaluate it alongside:
EBV VCA IgG
EBV VCA IgM
EBV Early Antigen (EA-D) IgG
Quantitative EBV DNA PCR when indicated
CBC with differential
Liver enzymes
CRP and/or ESR
Iron and nutrient status
Other markers of immune function or inflammation when clinically appropriate
We then monitor the patient's symptoms and laboratory trends over time, rather than treating one antibody value as a diagnosis by itself.
Our goal is not simply to make an antibody number fall. We want to see whether the patient's overall clinical picture is improving, including energy, exercise tolerance, lymph node swelling, recurrent sore throats, flu-like episodes, brain fog, and other symptoms, while continuing to evaluate for other potential contributors.
An EBNA IgG above 100 is therefore a threshold we use within our clinical approach to begin investigating, addressing, and following the EBV picture more closely, not a universally recognized diagnostic threshold for EBV reactivation.
Labs to Ask Your Provider About
If EBV is part of the clinical picture, discuss whether the following are appropriate:
EBV-specific testing
EBV VCA IgM
EBV VCA IgG
EBV EBNA IgG
EBV Early Antigen (EA-D) IgG
Quantitative EBV DNA PCR when clinically indicated
Supporting evaluation
CBC with differential
Comprehensive metabolic panel
AST/ALT
Ferritin and iron studies
CRP and/or ESR
Thyroid testing
Vitamin D
Vitamin B12/folate
Testing should always be selected and interpreted by a qualified healthcare provider based on symptoms, history and examination.
If you are experiencing any of the above symptoms we strongly recommend working with your provider or a provider to determine why
This article is intended for educational purposes and is not a substitute for medical diagnosis or individualized medical care.When We Begin Addressing Elevated EBNA IgG